Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.39 USD | -3.81% | -1.45% | -31.95% |
May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.95% | 2.64B | |
+16.71% | 121B | |
+13.27% | 107B | |
-5.75% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.50% | 15.31B | |
+2.16% | 14.08B | |
+24.35% | 11.74B |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- Wedbush Raises MoonLake Immunotherapeutics' PT to $86 From $61, Revisits Valuation Ahead of Data Readouts Expected in Q4; Keeps Outperform Rating